Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DragonFly System for Functional Mitral Regurgitation
NCT07243158Not yet recruiting
- Sponsor
- Valgen Medtech
- Start
- Dec 2025
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Valgen Medtech. Primary endpoint: Clinical success at 12 months after the procedure. Planned start Dec 2025; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07243158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07243158.